Trials / Enrolling By Invitation
Enrolling By InvitationNCT06843733
Feasibility Study of Mixed Reality Exergame on Performance and Cortical Outcomes
Feasibility Study of Mixed Reality Exergame on Performance and Cortical Outcomes in Healthy Older Adults and People with Mild Cognitive Impairment
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Mahidol University · Academic / Other
- Sex
- All
- Age
- 60 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The executive dysfunctions are a problem in individuals with MCI which predict conversion to dementia and is positively related to physical activity level. Previous studies found that exercise can prevent executive and physical dysfunctions for people with MCI. However, the motivation is a critical factor in supporting a sustainable exercise. Exergame is combination of exercise and video game. Enjoyment during playing an exergame can support the exercise motivation. Therefore, we will explore the feasibility of using MR exergame in people with MCI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Mixed reality exergame | The participants will play the Balloon Popping game using Hololens2 (Mixed reality glasses) for one hour. The objective of this game will be to pop all the virtual balloons, focusing on training different executive functions such as inhibitory control and cognitive flexibility. When a participant raises a finger in the air, a virtual needle will appear. After that, the participant will move their finger towards a balloon. Successful contact with a balloon will be indicated by the sound of a pop and the visual effect of confetti. |
| OTHER | Education | The participants will seat on a chair and watch video clip about MCI and dementia for one hour. |
Timeline
- Start date
- 2024-05-27
- Primary completion
- 2025-02-20
- Completion
- 2025-03-31
- First posted
- 2025-02-25
- Last updated
- 2025-02-28
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT06843733. Inclusion in this directory is not an endorsement.